BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 22710899)

  • 1. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management.
    Sokol L; Naghashpour M; Glass LF
    Cancer Control; 2012 Jul; 19(3):236-44. PubMed ID: 22710899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management.
    Wilcox RA
    Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University.
    Haverkos B; Tyler K; Gru AA; Winardi FK; Frederickson J; Hastings J; Elkins C; Zhang X; Xu-Welliver M; Wong HK; Porcu P
    Oncologist; 2015 Oct; 20(10):1161-6. PubMed ID: 26306900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea.
    Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS
    Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous B-cell lymphomas: 2016 update on diagnosis, risk-stratification, and management.
    Wilcox RA
    Am J Hematol; 2016 Oct; 91(10):1052-5. PubMed ID: 27650702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.
    Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL
    J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous B-cell lymphomas: 2013 update on diagnosis, risk-stratification, and management.
    Wilcox RA
    Am J Hematol; 2013 Jan; 88(1):73-6. PubMed ID: 23379008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management.
    Fava P; Roccuzzo G; Alberti-Violetti S; Grandi V; Pileri A; Pimpinelli N; Berti E; Quaglino P
    Presse Med; 2022 Mar; 51(1):104109. PubMed ID: 35026390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cutaneous B-cell lymphoma].
    Cortés B; Prins C
    Rev Med Suisse; 2014 Apr; 10(424):738, 740-3. PubMed ID: 24772806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
    Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
    G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management.
    Wilcox RA
    Am J Hematol; 2015 Jan; 90(1):73-6. PubMed ID: 25535037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous B-cell lymphomas - pathogenesis, diagnostic workup, and therapy.
    Nicolay JP; Wobser M
    J Dtsch Dermatol Ges; 2016 Dec; 14(12):1207-1224. PubMed ID: 27992127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification.
    Suárez AL; Pulitzer M; Horwitz S; Moskowitz A; Querfeld C; Myskowski PL
    J Am Acad Dermatol; 2013 Sep; 69(3):329.e1-13; quiz 341-2. PubMed ID: 23957984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous B-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.
    Hristov AC; Tejasvi T; Wilcox RA
    Am J Hematol; 2023 Aug; 98(8):1326-1332. PubMed ID: 37434388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions.
    Kempf W; Kazakov DV; Mitteldorf C
    Am J Dermatopathol; 2014 Mar; 36(3):197-208; quiz 209-10. PubMed ID: 24658377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas.
    Fabbri A; Cencini E; Alterini R; Rubegni P; Rigacci L; Delfino C; Puccini B; Fimiani M; Bosi A; Bocchia M; Pimpinelli N;
    Eur J Haematol; 2014 Aug; 93(2):129-36. PubMed ID: 24635751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous B-Cell Lymphoma.
    Goyal A; LeBlanc RE; Carter JB
    Hematol Oncol Clin North Am; 2019 Feb; 33(1):149-161. PubMed ID: 30497672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous B-cell lymphoma: important diagnostic tools.
    Ferenczi K
    G Ital Dermatol Venereol; 2010 Jun; 145(3):361-73. PubMed ID: 20461044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in primary cutaneous B-cell lymphomas.
    Vermeer MH; Willemze R
    Curr Opin Oncol; 2014 Mar; 26(2):230-6. PubMed ID: 24463347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous primary B-cell lymphomas: from diagnosis to treatment.
    Lima M
    An Bras Dermatol; 2015; 90(5):687-706. PubMed ID: 26560215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.